US Patent Issued to Biohaven Therapeutics on July 22 for "Use of riluzole oral disintegrating tablets for treating diseases" (Connecticut, New Jersey Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,687, issued on July 22, was assigned to Biohaven Therapeutics Ltd. (Tortola, British Virgin Islands).

"Use of riluzole oral disintegrating tablets for treating diseases" was invented by Vladimir Coric (Madison, Conn.), Robert Berman (New Haven, Conn.) and Irfan Qureshi (Hackensack, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating a disease in a patient in need thereof, comprising administering to the patient a pharmaceutical composition comprising a therapeutically effective amount of riluzole, or a pharmaceutically acceptable salt thereof, in the form of an oral solid molded fast-dispersing dosage form. Pharmace...